Paradoxical whole genome DNA methylation dynamics of 5’aza-deoxycytidine in chronic low-dose exposure in mice

References

• Gnyszka A, Jastrzȩbski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013.33(8):2989–2896
   Google Scholar
• Oki Y, Aoki E, Issa JPJ. Decitabine-Bedside to bench. Crit Rev Oncol Hematol. 2007;61(2):140–152.
   Google Scholar
• Diesch J, Zwick A, Garz A-K, et al. A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. Clin Epigenetics. 2016;8(1). DOI:10.1186/s13148-016-0237-y
   Google Scholar
• Momparler RL. Pharmacology of 5-aza-2′-deoxycytidine (decitabine). Semin Hematol. 2005;42:S9-S16.
   Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–254.
   Google Scholar
• Karahoca M, Momparler RL. Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′- deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin Epigenetics. 2013;5(1):3.
   Google Scholar
• Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol. 2006. DOI:10.1007/3-540-31390-7_7
   Google Scholar
• Patel K, Dickson J, Din S, et al. Targeting of 5-aza-2ʹ-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res. 2010;38(13):4313–4324.
   Google Scholar
• Hattori N, Sako M, Kimura K, et al. Novel prodrugs of decitabine with greater metabolic stability and less toxicity. Clin Epigenetics. 2019;11(1). DOI:10.1186/s13148-019-0709-y
   Google Scholar
• Stresemann C, Brueckner B, Musch T, et al. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 2006;66(5):2794–2800.
   Google Scholar
• Viet CT, Dang D, Achdjian S, et al. Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma e112880. PLoS One. 2014;9(11):e112880.
   Google Scholar
• Raynal Noël J.-M., Issa Jean-Pierre J.. Chapter 7 – DNA methyltransferase inhibitors. Drug Discovery in Cancer Issa. 2016. doi: 10.1016/B978-0-12-802208-5.00007-2.
   Google Scholar
• Kaminskas E. FDA drug approval summary: azacitidine (5-azacytidine, Vidaza™) for injectable suspension. Oncologist. 2005;10(3):176–182.
   Google Scholar
• Jaenisch R, Schnieket A, Harbers K, et al. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues (toxicity of 5-azacytidine/in vivo activation of transcription/recombination of defective proviral genomes). Cell Biol. 1985.82(5):1451–1455
   Google Scholar
• Lillo Osuna MA, Garcia-Lopez J, El Ayachi I, et al. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. Cancer Res. 2019;79(6):1054-1068. doi: 10.1158/0008-5472.CAN-18-1255.
   Google Scholar
• Flotho C, Claus R, Batz C, et al. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009;23(6):1019–1028.
   Google Scholar
• Plumb JA, Strathdee G, Sludden J, et al. Reversal of drug resistance in human tumor xenografts by 2ʹ-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res. 2000;60(21):6039–6044.
   Google Scholar
• Molokie R, Lavelle D, Gowhari M, et al. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLoS Med. 2017;14(9):e1002382.
   Google Scholar
• Kelly TLJ, Li E, Trasler JM. 5-Aza-2′-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome. J Androl. 2003;24(6):822–830.
   Google Scholar
• Qin T, Jelinek J, Si J, et al. Mechanisms of resistance to 5-aza-2ʹ-deoxycytidine in human cancer cell lines. Blood. 2009;113(3):659–667.
   Google Scholar
• Doerksen T, Benoit G, Trasler JM. Deoxyribonucleic acid hypomethylation of male germ cells by mitotic and meiotic exposure to 5-azacytidine is associated with altered testicular histology. Endocrinology. 2000;141(9):3235–3244.
   Google Scholar
• Wong CC, Kang W, Xu J, et al. Prostaglandin E2 induces DNA hypermethylation in gastric cancer in vitro and in vivo. Theranostics. 2019;9(21):6256–6268.
   Google Scholar
• Anders NM, Liu J, Wanjiku T, et al. Simultaneous quantitative determination of 5-aza-2ʹ-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2016;1022:38–45.
   Google Scholar
• Juttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2ʹ-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA. 1994;91(25):11797–11801.
   Google Scholar
• Terse P, Engelke K, Chan K, et al. Subchronic oral toxicity study of decitabine in combination with tetrahydrouridine in CD-1 mice. Int J Toxicol. 2014;33(2):75–85.
   Google Scholar
• Momparler RL, Frith CH. Toxicology in mice of the antileukemic agent 5-AZA-2ʹ-deoxycytidine. Drug Chem Toxicol. 1981;4(4):373–381.
   Google Scholar
• Cao Q, Wang X, Jia L, et al. Inhibiting DNA methylation by 5-Aza-2ʹ-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014;155(12):4925–4938.
   Google Scholar
• Weinhouse C, Anderson OS, Bergin IL, et al. Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A. Environ Health Perspec. 2014;122(5):485–491.
   Google Scholar
• Kochmanski J, Vanoeveren SE, Patterson JR, et al. Developmental dieldrin exposure alters DNA methylation at genes related to dopaminergic neuron development and Parkinson’s disease in mouse midbrain. Toxicol Sci. 2019;169(2):593–607.
   Google Scholar
• Andrews S. FASTQC A quality control tool for high throughput sequence data. Babraham Inst. 2015.
   Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120.
   Google Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: A fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–360.
   Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511–515.
   Google Scholar
• Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019. DOI:10.1093/nar/gkz114
   Google Scholar
• MD R, DJ M, GK S. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140.
   Google Scholar
• Illumina. Sequencing methods review (A review of publications featuring Illumina Technology). Illumina Protoc. 2014.
   Google Scholar
• Krueger F. Trim Galore!: A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files. Babraham Institute. 2015. doi:10.1002/maco.200603986.
   Google Scholar
• Krueger F, Andrews SR. Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27(11):1571–1572.
   Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359.
   Google Scholar
• Park Y, Wu H. Differential methylation analysis for BS-seq data under general experimental design. Bioinformatics. 2016;32(10):1446–1453.
   Google Scholar
• Cavalcante RG, Sartor M. A. annotatr: associating genomic regions with genomic annotations. bioRxiv. 2016;1–9. DOI:10.1101/039685
   Google Scholar
• Lemaire M. Importance of dose-schedule of 5-aza-2′-deoxycytidine for epigenetic therapy of cancer. BMC Cancer. 2008;8:128.
   Google Scholar
• Song N, Endo D, Song B, et al. 5-aza-2′-deoxycytidine impairs mouse spermatogenesis at multiple stages through different usage of DNA methyltransferases. Toxicol. 2016;361-362:62–72.
   Google Scholar
• Kläver R, Sánchez V, Damm OS, et al. Direct but no transgenerational effects of decitabine and vorinostat on male fertility. PLoS One. 2015;10(2):e0117839.
   Google Scholar
• Ito Y, Nativio R, Murrell A. Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus. Nucleic Acids Res. 2013;41(10):5290–5302.
   Google Scholar
• Wang Y, Su J, Wang L, et al. The effects of 5-Aza-2′- deoxycytidine and trichostatin a on gene expression and DNA methylation status in cloned bovine blastocysts. Cell Reprogram. 2011;13(4):297–306.
   Google Scholar
• Eversole-Cire P, Ferguson-Smith AC, Sasaki H et al. Activation of an imprinted Igf 2 gene in mouse somatic cell cultures. Mol Cell Biol. 2015. DOI:10.1128/mcb.13.8.4928.
   Google Scholar
• Bourc’his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature. 2004;431(7004):96–99.
   Google Scholar
• Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc Natl Acad Sci. 2006. DOI:10.1073/pnas.82.5.1451
   Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9(16):2395–2402.
   Google Scholar
• Jabbour E, Issa JP, Garcia-Manero G, et al. Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies. Cancer. 2008;112(11):2341–2351.
   Google Scholar
• Chuang JC, Warner SL, Vollmer D, et al. S110, a 5-Aza-2ʹ-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Mol Cancer Ther. 2010;9(5):1443–1450.
   Google Scholar
• Francis WR, Wörheide G. Similar ratios of introns to intergenic sequence across animal genomes. Genome Biol Evol. 2017;9(6):1582–1598.
   Google Scholar
• Yang AS. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32(3):38e-38.
   Google Scholar
• Yang AS, Doshi KD, Choi S-W, et al. DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res. 2006;66(10):5495–5503.
   Google Scholar
• Dolinoy DC. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev. 2008;66 Suppl 1(Suppl 1): S7–S11.
   Google Scholar
• Davis CM, Constantinides PG, Gevers W, et al. Activation and demethylation of the intracisternal A particle genes by 5-azacytidine. Cell Differ Dev. 1989;27(2):83–93.
   Google Scholar
• Lasneret J. Electron microscopic characterisation of retrovirus and retrovirus-like particles induced by demethylating agents (5-azacytidine and 5-azadeoxycytidine) in Syrian hamster (Mesocrisetus auratus) cells. J Exp Pathol. 1989;4(1):47–56.
   Google Scholar
• Kao T-H, Liao H-F, Wolf D, et al. Ectopic DNMT3L triggers assembly of a repressive complex for retroviral silencing in somatic cells. J Virol. 2014;88(18):10680–10695.
   Google Scholar